Effects of overexpression of growth hormone on T cell activity in transgenic mice.
Growth hormone plays a key role in the maturation and maintenance of the immune response, however, the effects of chronic high circulating concentrations of the hormone on the immune system is poorly understood. Transgenic mice overexpressing bovine growth hormone (b-GH) gene, fused to the rat phosphoenolpyruvate carboxykinase promoter (PEPCK), with very high plasma concentration of heterologous b-GH and their littermate normal siblings were used. Spleen cellularity, percentages of total T lymphocytes, CD4+ and CD8+ cells, ratio of T cell subpopulations, mitogen-induced lymphocyte proliferation and natural killer (NK) cell activity were examined in male transgenic mice and normal littermate mice at 2 and 6 months of age. The number of splenic lymphocytes was greater in transgenic mice than in matched normal littermates at both ages. The NK cell activity was lower in transgenic mice than in the matched normal littermates at both ages, with the lowest values found in older mice. The b-GH transgenic mice had lower percentages of T cells at both ages, however, in young transgenic mice, the percentage of CD4+ cells was reduced while percentage of CD8+ cells was increased in comparison to normal controls. Both basal and mitogen-induced proliferation capacity of splenocytes were reduced in PEPCK-b-GH-25 mice as compared to normal littermates of both ages. Proliferative indexes in response to concanavalin A and phytohemagglutinin were markedly decreased in 6 month old PEPCK-b-GH-25 mice as compared to littermate controls or younger mice. These results indicate that overexpression of b-GH in mice is associated with decreased T cell function and that these abnormalities are age-dependent.
Esquifino
A I
AI
Departamento de Bioquímica y Biología Molecular III, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain. esquifino@yahoo.es
Arce
A
A
Alvarez
M P
MP
Szary
A
A
Brown-Borg
H
H
Bartke
A
A
D000367:Age Factors; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology; D018414:CD8-Positive T-Lymphocytes / Q000502:physiology; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D005260:Female; D005786:Gene Expression Regulation; D013006:Growth Hormone / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D007694:Killer Cells, Natural / Q000502:physiology; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008934:Mitogens / Q000494:pharmacology; D019764:Phosphoenolpyruvate Carboxykinase (ATP) / Q000235:genetics; D011401:Promoter Regions, Genetic; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013601:T-Lymphocytes / Q000502:physiology*
D008934:Mitogens; D013006:Growth Hormone; D019764:Phosphoenolpyruvate Carboxykinase (ATP)